New Study Links Immune Cells to Alzheimer's Risk

Recent scientific breakthroughs have fundamentally changed our understanding of Alzheimer's disease (AD).

Once seen primarily as a buildup of toxic proteins, researchers now recognize AD as a complex disorder of the brain's immune system.

Microglia, the brain's resident defenders, act as a double-edged sword.

While they normally clear harmful debris, chronic activation causes them to release toxic substances that damage healthy neurons.

Furthermore, recent studies highlight that peripheral cells, such as T cells and neutrophils, can infiltrate the brain when the blood-brain barrier weakens, worsening inflammation.

Even more striking is the discovery that microglia can accumulate genetic mutations over time, rendering them dysfunctional.

The STING pathway, which triggers inflammation in response to DNA damage, further highlights how the brain's defense mechanism can turn against itself.

These findings are revolutionary, moving medical focus toward precision immunotherapy.

Instead of only targeting protein plaques, scientists are now testing ways to 're-educate' immune cells and using simple blood tests to predict dementia risk years before symptoms appear.